Main Menu

Childhood cancers

The Institute of Cancer Research, London is an internationally leading research centre in the study of childhood cancers and cancers in children, teenagers and young adults.

Our researchers often play leading roles in European and international research efforts that are transforming how these devastating diseases are treated, as well as pioneering studies of cancer types not studied elsewhere in the UK.

Scientists including Professor Sir Mel Greaves, whose work has underpinned new treatments for leukaemias and pioneered new understandings of its causes, are renowned in their fields. 

Meet our researchers

Our impact on childhood cancer

ICR researchers working with our partner hospital The Royal Marsden NHS Foundation Trust have led major international clinical trials of new drugs that have changed the standard of care in neuroblastoma, the most commonly fatal solid tumours in children. Neuroblastoma also continues to be a major focus for our scientists in the laboratory.

A new generation of researchers is making strides towards new treatments for relatively under-studied cancers affecting children and young adults – including high grade gliomas, including glioblastoma and DIPG, rhabdomyosarcoma, Ewing’s sarcoma, osteosarcoma,  malignant rhabdoid tumour and desmoplastic small round cell tumour.

Our research into these tumours is often carried out thanks to the support of our network of passionate family charity partners, who have directly experienced the devastating impact of childhood cancer and whose fundraising efforts are leading, through research at the ICR, to unprecedented insights into these diseases.

Support our research

Latest news on childhood cancer

Childhood leukaemia appeal

Our latest research shows that within the next decade, we can make acute lymphoblastic leukaemia preventable. Your support will help us make this disease a thing of the past.